<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>1(3)</volume><submitter>Wen J</submitter><pubmed_abstract>Alpha7 nicotinic acetylcholine receptor (α7 nAChR), a hub of the cholinergic anti-inflammatory pathway (CAP), is required for the treatment of inflammatory diseases. HIV-1 infection can upregulate the expression of α7 nAChR in T lymphocytes and affect the role of CAP. However, whether α7 nAChR regulates HIV-1 infection in CD4&lt;sup>+&lt;/sup> T cells is unclear. In this study, we first found that activation of α7 nAChR by GTS-21 (an α7 nAChR agonist) can promote the transcription of HIV-1 proviral DNA. Then, through transcriptome sequencing analysis, we found that p38 MAPK signaling was enriched in GTS-21 treated HIV-latent T cells. Mechanistically, activation of α7 nAChR could increase reactive oxygen species (ROS), reduce &lt;i>DUSP1&lt;/i> and &lt;i>DUSP6&lt;/i>, and consequently enhance the phosphoryla</pubmed_abstract><journal>Cell insight</journal><pagination>100028</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10120325</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Activation of α7 nicotinic acetylcholine receptor promotes HIV-1 transcription.</pubmed_title><pmcid>PMC10120325</pmcid><pubmed_authors>Wen J</pubmed_authors><pubmed_authors>Zhao C</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Qi H</pubmed_authors><pubmed_authors>Song S</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Su X</pubmed_authors><pubmed_authors>Xie S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Activation of α7 nicotinic acetylcholine receptor promotes HIV-1 transcription.</name><description>Alpha7 nicotinic acetylcholine receptor (α7 nAChR), a hub of the cholinergic anti-inflammatory pathway (CAP), is required for the treatment of inflammatory diseases. HIV-1 infection can upregulate the expression of α7 nAChR in T lymphocytes and affect the role of CAP. However, whether α7 nAChR regulates HIV-1 infection in CD4&lt;sup>+&lt;/sup> T cells is unclear. In this study, we first found that activation of α7 nAChR by GTS-21 (an α7 nAChR agonist) can promote the transcription of HIV-1 proviral DNA. Then, through transcriptome sequencing analysis, we found that p38 MAPK signaling was enriched in GTS-21 treated HIV-latent T cells. Mechanistically, activation of α7 nAChR could increase reactive oxygen species (ROS), reduce &lt;i>DUSP1&lt;/i> and &lt;i>DUSP6&lt;/i>, and consequently enhance the phosphoryla</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-19T06:41:27.99Z</modification><creation>2025-04-19T06:41:27.99Z</creation></dates><accession>S-EPMC10120325</accession><cross_references><pubmed>37193048</pubmed><doi>10.1016/j.cellin.2022.100028</doi></cross_references></HashMap>